Véronique Leblond
- Genetics top 0.1%
- Chronic Lymphocytic Leukemia Research 121
- Hematology top 0.2%
- Multiple Myeloma Research and Treatments 17
- Pathology and Forensic Medicine top 0.2%
- Lymphoma Diagnosis and Treatment 99
- Oncology top 1%
- Viral-associated cancers and disorders 32
- Polyomavirus and related diseases 15
- Immunology top 2%
- Immunodeficiency and Autoimmune Disorders 41
-
- Acute Lymphoblastic Leukemia research 21
-
- CNS Lymphoma Diagnosis and Treatment 18
- Co-authors
- Sylvain ChoquetJean‐Paul FermandSteven P. TreonFrançois DreyfusOlivier HermineMeletios Α. DimopoulosSylvie ChevretArnaud Jaccard
- Journals
- New England Journal of Medicine (3 papers)Journal of Clinical Oncology (11 papers)SHILAP Revista de lepidopterología (2 papers)
- Partner nations
- FranceGermanyUnited States
In The Last Decade
Véronique Leblond
209 papers receiving 7.0k citations
Peers
Comparison fields: 5 of 112
- Genetics 3.1k
- Hematology 2.1k
- Pathology and Forensic Medicine 3.1k
- Oncology 2.5k
- Immunology 1.3k
Countries citing papers authored by Véronique Leblond
This map shows the geographic impact of Véronique Leblond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Véronique Leblond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Véronique Leblond more than expected).
Fields of papers citing papers by Véronique Leblond
This network shows the impact of papers produced by Véronique Leblond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Véronique Leblond. The network helps show where Véronique Leblond may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Véronique Leblond, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 1 | |
| 5 | 2022 | 1 | |
| 6 | 2022 | 4 | |
| 7 | 2021 | 24 | |
| 8 | 2021 | 11 | |
| 9 | 2021 | 21 | |
| 10 | 2020 | 6 | |
| 11 | 2019 | 8 | |
| 12 | 2018 | 15 | |
| 13 | 2017 | 47 | |
| 14 | 2017 | 5 | |
| 15 | 2014 | 42 | |
| 16 | 2013 | 125 | |
| 17 | 2011 | 4 | |
| 18 | 2010 | 96 | |
| 19 | 2009 | 228 | |
| 20 | 2008 | 4 |
About Véronique Leblond
Véronique Leblond is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology, having authored 218 papers that have together received 7.2k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (121 papers), Lymphoma Diagnosis and Treatment (99 papers), Immunodeficiency and Autoimmune Disorders (41 papers), Viral-associated cancers and disorders (32 papers), Acute Lymphoblastic Leukemia research (21 papers), CNS Lymphoma Diagnosis and Treatment (18 papers), Multiple Myeloma Research and Treatments (17 papers) and Polyomavirus and related diseases (15 papers). The work is most often cited by research in Genetics (3.1k citations), Hematology (2.1k citations) and Pathology and Forensic Medicine (3.1k citations). Véronique Leblond has collaborated with scholars based in France, Germany and United States. Frequent co-authors include Sylvain Choquet, Jean‐Paul Fermand, Steven P. Treon, François Dreyfus, Olivier Hermine, Meletios Α. Dimopoulos, Sylvie Chevret, Arnaud Jaccard, Marine Diviné and Margaret Macro. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.